Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Halfords Group PLC: Proposed closure of Cycle Republic and Boardman Performance Centre
Halfords Group PLC: Proposed closure of Cycle Republic and Boardman Performance Centre
Halfords Group PLC: Proposed closure of Cycle Republic and Boardman Performance Centre
Holding in Company
Holding in Company
Holding in Company
Total Voting Rights
Total Voting Rights
Total Voting Rights
Hardman & Co Research: Shield Therapeutics (STX): Good demand for Feraccru in Europe
Hardman & Co Research: Shield Therapeutics (STX): Good demand for Feraccru in Europe
Hardman & Co Research: Shield Therapeutics (STX): Good demand for Feraccru in Europe
Director/PDMR Shareholding
Director/PDMR Shareholding
Director/PDMR Shareholding
Director/PDMR Shareholding
Director/PDMR Shareholding
Director/PDMR Shareholding
Halfords Group PLC: FY20 40-week trading update
Halfords Group PLC: FY20 40-week trading update
Halfords Group PLC: FY20 40-week trading update
Hardman & Co Research: Shield Therapeutics (STX): Taking on China
Hardman & Co Research: Shield Therapeutics (STX): Taking on China
Hardman & Co Research: Shield Therapeutics (STX): Taking on China
Holding in Company
Holding in Company
Holding in Company
Halfords Group PLC: Holding(s) in Company
Halfords Group PLC: Holding(s) in Company
Halfords Group PLC: Holding(s) in Company
Hardman & Co Research: Shield Therapeutics (STX): More choice for clinicians and patients
Hardman & Co Research: Shield Therapeutics (STX): More choice for clinicians and patients
Hardman & Co Research: Shield Therapeutics (STX): More choice for clinicians and patients
2 Beaten-Down Stocks That Could Make You Richer: https://g.foolcdn.com/editorial/images/768265/pharmacist-talking-to-patient.jpg
2 Beaten-Down Stocks That Could Make You Richer

Becoming richer by investing in stocks usually doesn't happen overnight. It takes years -- sometimes decades -- of patience and holding on to shares of companies that aren't always performing as

CVS Health's Earnings Crashed 37% in Q2: Should Investors Be Worried?: https://g.foolcdn.com/editorial/images/744780/people-crowding-around-a-computer.jpg
CVS Health's Earnings Crashed 37% in Q2: Should Investors Be Worried?

Shares of CVS Health (NYSE: CVS) have nosedived 28% so far in 2023. The company's business performance has disappointed this year with the bottom line falling by a whopping 37% in the most recent

Is CVS Stock a Buy After the Recent Drop?: https://g.foolcdn.com/editorial/images/744629/cvs.png
Is CVS Stock a Buy After the Recent Drop?

In this video, I will talk about CVS (NYSE: CVS), which dropped 9% on Thursday because Blue Shield of California decided to drop it and go with five other vendors for PBM services. CVS stock is down

Why CVS Health Stock Crashed 11 Percent Today: https://g.foolcdn.com/editorial/images/744532/1-simple-red-arrow-declining-stock-chart-on-a-white-checked-background.jpg
Why CVS Health Stock Crashed 11 Percent Today

Shares of drugstore chain and pharmacy benefits manager CVS Health (NYSE: CVS) got hammered Thursday morning, falling 11% through 10:35 a.m. ET after Reuters reported a big client loss for the

Amazon's Online Pharmacy Just Landed a Big Deal With Blue Shield of California. Is the Stock a Buy?: https://g.foolcdn.com/editorial/images/744519/woman-holding-prescription-bottle-looking-at-laptop.jpg
Amazon's Online Pharmacy Just Landed a Big Deal With Blue Shield of California. Is the Stock a Buy?

Amazon (NASDAQ: AMZN) launched its online pharmacy in November 2020. Some might have wondered at the time just how big of a splash the e-commerce giant would make in the pharmacy industry. We now

Why Guardant Health's Shares Climbed This Week: https://g.foolcdn.com/editorial/images/732210/healthcare-lab-treatment-research-scientist-1.jpg
Why Guardant Health's Shares Climbed This Week

Shares of Guardant Health (NASDAQ: GH) were up 14.8% for the week as of Thursday afternoon and rose as much as 19.8% for the week, according to data provided by S&P Global Market Intelligence. The h

Superdry plc: Result of General Meeting
Superdry plc: Result of General Meeting
Superdry plc: Result of General Meeting
Superdry plc: Restructuring Plan – Results of meetings of the Plan Creditors
Superdry plc: Restructuring Plan – Results of meetings of the Plan Creditors
Superdry plc: Restructuring Plan – Results of meetings of the Plan Creditors
Superdry plc: Total Voting Rights
Superdry plc: Total Voting Rights
Superdry plc: Total Voting Rights
Halfords Group PLC: Total Voting Rights
Halfords Group PLC: Total Voting Rights
Halfords Group PLC: Total Voting Rights
Halfords Group PLC: Notice of Preliminary Results Announcement
Halfords Group PLC: Notice of Preliminary Results Announcement
Halfords Group PLC: Notice of Preliminary Results Announcement
Hardman & Co: Shield Therapeutics (STX): Cash management is key
Hardman & Co: Shield Therapeutics (STX): Cash management is key
Hardman & Co: Shield Therapeutics (STX): Cash management is key
Superdry plc: Posting of Circular and Notice of General Meeting
Superdry plc: Posting of Circular and Notice of General Meeting
Superdry plc: Posting of Circular and Notice of General Meeting
Halfords Group PLC: Holding(s) in Company
Halfords Group PLC: Holding(s) in Company
Halfords Group PLC: Holding(s) in Company